CANNABINOIDS FOR THERAPEUTIC PURPOSES
- Synthetic THC analog
- Prescribed in 0.25, 0.5 and 1mg capsules for oral administration
- Oral antiemetic
- Brand name: Cesamet®
- Product Information
DRONABINOL
- Synthetic THC analog
- Prescribed in 2.5, 5 and 10 mg capsules for oral administration
- Prescribed for the treatment of AIDS-related anorexia associated with weight loss.
- Brand name: Marinol®
NABIXIMOLS (1 THC : 1 CBD)
- Standard marketing authorisation as adjunctive treatment for symptomatic relief of spasticity in adult patients with multiple sclerosis (MS) who have not responded adequately to other therapy and who demonstrate meaningful improvement during an initial trial of therapy.
- Marketing authorization with conditions: Sativex® may be useful as adjunctive treatment for the symptomatic relief of neuropathic pain in adult patients with MS.
- Marketing authorization with conditions: Sativex® may be useful as adjunctive analgesic treatment in adult patients with advanced cancer who experience moderate to severe pain during the highest tolerated dose of strong opioid therapy for persistent background pain.
- Common name: Sativex®
CANNABIS
- Dried herbal cannabis
- Available for medical use through the Marihuana for Medical Purposes Regulations (MMPR)
- Percentages of Delta 9-tetrahydrocannabinol (THC) and cannabidiol (CBD) must be indicated
- Frequently Asked Questions about the MMPR